Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Vascular Damage”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Early research (Phase 1)Study completedNCT00731302
What this trial is testing

Aspirin Resistance in Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Vanderbilt University 70
Post-approval studies (Phase 4)Enrolling By InvitationNCT07343661
What this trial is testing

Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA

Who this might be right for
EGPA - Eosinophilic Granulomatosis With PolyangiitisSevere AsthmaEosinophilic Asthma
Azienda Ospedaliero Universitaria di Cagliari 90
Not applicableLooking for participantsNCT06613555
What this trial is testing

Retinal Microvascularization in OCT-angiography and Systemic Diseases

Who this might be right for
Systemic Vascular Damage
Centre Hospitalier Universitaire Dijon 5,000
Not applicableStudy completedNCT03115502
What this trial is testing

Hemodynamic Changes and Vascular Tone Control After Bariatric Surgery

Who this might be right for
Systemic Vascular Resistance
Parc de Salut Mar 50
Not applicableStudy completedNCT01616472
What this trial is testing

WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 1
Large-scale testing (Phase 3)Study completedNCT03164473
What this trial is testing

Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.

Who this might be right for
Eosinophilic Granulomatosis With Polyangiitis
Assistance Publique - Hôpitaux de Paris 98